Wize Pharma Inc   Report issue

For profit Phase 2 Phase 4
Founded: Hod Hasharon Israel (1982)
Status: No NME R&D (1982)

Organization Overview

First Clinical Trial
2016
NCT02804191
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Ocuwize LTD

Active Ingredients

Drugs in Phase 4 Trials (3)

hyaluronic acid (1 trial)

polyethylene glycol (1 trial)

propylene glycol (1 trial)

Drugs in Phase 2 Trials (2)

leuprolide (lupron) (2 trials)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dry Eye Syndromes (Phase 4)

Keratoconjunctivitis Sicca (Phase 4)

Sjogren's Syndrome (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5